{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:34:02Z","timestamp":1732772042474,"version":"3.29.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.gastrohep.2024.502195","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T08:50:33Z","timestamp":1714985433000},"page":"502195","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination of granulocyte\u2013monocyte apheresis and ustekinumab: Multicentre and retrospective study"],"prefix":"10.1016","volume":"47","author":[{"given":"Iago","family":"Rodr\u00edguez-Lago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Herrera-deGuise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Bosc\u00e1-Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Leo-Carnerero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Calvo","family":"\u00cd\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Cuar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainara","family":"Elorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Guerra-del-R\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dami\u00e1n","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Barreiro-de Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ginard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Cabriada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2024.502195_bib0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leukocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Transf Apher Sci"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0200","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.dld.2004.08.004","article-title":"Clinical evaluation of granulocyte\/monocyte apheresis therapy for active ulcerative colitis","volume":"36","author":"Kanke","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0205","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.2169\/internalmedicine.8428-16","article-title":"Long-interval cytapheresis as a novel therapeutic strategy leading to dosage reduction and discontinuation of steroids in steroid-dependent ulcerative colitis","volume":"56","author":"Iizuka","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1744-9987.12485","article-title":"Granulocyte\u2013monocyte apheresis as an adjuvant therapy to anti-tumor necrosis factor drugs for ulcerative colitis","volume":"21","author":"Rodr\u00edguez-Lago","year":"2017","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0215","unstructured":"Adacolumn information and technical support. Available from: https:\/\/www.adacyte.com\/professional\/products\/adacolumn\/ [accessed December 2023]."},{"key":"10.1016\/j.gastrohep.2024.502195_bib0220","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jca.21746","article-title":"The combination of granulocyte\u2013monocyte apheresis and vedolizumab: a new treatment option for ulcerative colitis?","volume":"34","author":"Rodr\u00edguez-Lago","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0225","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/17474124.2022.2100759","article-title":"Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis","volume":"16","author":"Bamias","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0230","first-page":"5156","article-title":"The combined efficacy of adalimumab with GMA method on the treatment of ulcerative colitis and repair of intestinal mucosal lesion","volume":"13","author":"Song","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0235","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ecco-jcc\/jjaa051","article-title":"Efficacy of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease showing lost response to infliximab","volume":"14","author":"Yokoyama","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.14740\/jocmr4887","article-title":"Induction therapy with a combination of weekly adalimumab plus intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis and failure of conventional agents biologics and Janus kinase inhibitor","volume":"15","author":"Tanida","year":"2023","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00535-011-0499-2","article-title":"Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry","volume":"47","author":"Cabriada","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0250","unstructured":"Stelara summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/stelara-epar-product-information_en.pdf [accessed December 2023]."},{"key":"10.1016\/j.gastrohep.2024.502195_bib0255","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ecco-jcc\/jjac030","article-title":"Efficacy and safety of maintenance ustekinumab for ulcerative colitis through 3 years: UNIFI long-term extension","volume":"16","author":"Abreu","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0260","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.gastrohep.2024.502195_bib0265","first-page":"8","article-title":"Efficacy of ustekinumab for ulcerative colitis through 4 years: final clinical and endoscopy outcomes from the UNIFI long-term extension","volume":"19","author":"Danese","year":"2023","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0270","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/apt.15717","article-title":"Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study","volume":"51","author":"Amiot","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0275","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/ecco-jcc\/jjab070","article-title":"Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from the ENEIDA registry","volume":"15","author":"Chaparro","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0280","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/apt.16544","article-title":"Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study","volume":"54","author":"Fumery","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ueg2.12275","article-title":"Ustekinumab treatment in ulcerative colitis: real-world data from the Swedish inflammatory bowel disease quality register","volume":"10","author":"Thunberg","year":"2022","journal-title":"Unit Eur Gastroenterol J"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0290","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.cgh.2021.03.028","article-title":"Predictors and outcomes of ustekinumab dose intensification in ulcerative colitis: a multicenter cohort study","volume":"20","author":"Dalal","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ibd\/izab015","article-title":"Re-induction with intravenous ustekinumab in patients with crohn's disease and a loss of response to this therapy","volume":"28","author":"Bermejo","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/1744-9987.12697","article-title":"Combination therapy with intensive granulocyte and monocyte adsorptive apheresis plus ustekinumab in patients with refractory Crohn's disease","volume":"22","author":"Tanida","year":"2018","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0305","doi-asserted-by":"crossref","first-page":"510","DOI":"10.14740\/jocmr4625","article-title":"Combination therapy with ustekinumab plus intensive granulocyte and monocyte adsorptive apheresis in patients with refractory ulcerative colitis","volume":"13","author":"Tanida","year":"2021","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0310","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0315","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gastrohep.2020.07.001","article-title":"GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach","volume":"43","author":"Sicilia","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0325","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/00365521.2018.1447598","article-title":"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis","volume":"53","author":"Dignass","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0330","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.3748\/wjg.v28.i34.4959","article-title":"Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy","volume":"28","author":"Iizuka","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0335","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jca.20242","article-title":"Selective depletion of peripheral granulocyte\/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease","volume":"25","author":"Fukunaga","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0340","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3748\/wjg.v27.i10.908","article-title":"Use of granulocyte\/monocyte apheresis in ulcerative colitis: a practical review from a European perspective","volume":"27","author":"Dom\u00e8nech","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0345","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid N\u00e4ive patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0350","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/ajg.2009.453","article-title":"An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment","volume":"104","author":"Sakuraba","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0355","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2017.12.030","article-title":"Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte\/monocyte apheresis: a case series","volume":"103","author":"Yokoyama","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0360","article-title":"An in vitro analysis of the interaction between infliximab and granulocyte\u2013monocyte apheresis","author":"Rodr\u00edguez Lago","year":"2023","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0365","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/apt.17386","article-title":"Meta-analysis: real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis","volume":"57","author":"Taxonera","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0370","first-page":"izac275","article-title":"Efficacy effectiveness, and safety of ustekinumab for the treatment of ulcerative colitis: a systematic review","author":"Gisbert","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.crohns.2010.04.004","article-title":"Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects","volume":"4","author":"Allez","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2024.502195_bib0380","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.gastrohep.2018.04.007","article-title":"Granulocyte and monocyte apheresis in inflammatory bowel disease: the patients\u2019 point of view","volume":"41","author":"Rodr\u00edguez-Lago","year":"2018","journal-title":"Gastroenterol Hepatol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524001535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524001535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:43:00Z","timestamp":1732732980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570524001535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0210570524001535"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502195","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of granulocyte\u2013monocyte apheresis and ustekinumab: Multicentre and retrospective study","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502195"}}